




Searching News Database: H5N1
HSMN NewsFeed - 8 Jun 2020
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
HSMN NewsFeed - 18 Nov 2009
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
HSMN NewsFeed - 19 Feb 2008
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
HSMN NewsFeed - 11 Feb 2008
HepaLife's Bioartificial Liver Dramatically Reduces Toxic Marker for Acute Liver Failure
HepaLife's Bioartificial Liver Dramatically Reduces Toxic Marker for Acute Liver Failure
HSMN NewsFeed - 1 Nov 2007
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
HSMN NewsFeed - 26 Sep 2007
HepaLife(TM) Releases Positive New Research Results for First-of-Its-Kind Bioartificial Liver
HepaLife(TM) Releases Positive New Research Results for First-of-Its-Kind Bioartificial Liver
HSMN NewsFeed - 13 Aug 2007
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
HSMN NewsFeed - 9 Jul 2007
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
HSMN NewsFeed - 15 Jun 2007
Former President and CEO of Biomira Alex McPherson Joins Carrington Board of Directors
Former President and CEO of Biomira Alex McPherson Joins Carrington Board of Directors
HSMN NewsFeed - 13 Jun 2007
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
HSMN NewsFeed - 30 Apr 2007
HepaLife Achieves Major Milestone in Development of Artificial Liver Device
HepaLife Achieves Major Milestone in Development of Artificial Liver Device
HSMN NewsFeed - 14 Mar 2007
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
HSMN NewsFeed - 25 Jan 2007
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
HSMN NewsFeed - 14 Jun 2006
BioCryst and Green Cross Enter Agreement to Develop and Commercialize Peramivir in South Korea
BioCryst and Green Cross Enter Agreement to Develop and Commercialize Peramivir in South Korea
HSMN NewsFeed - 19 May 2006
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder
HSMN NewsFeed - 30 Mar 2006
GlaxoSmithKline Initiates Human Trial Program With Two H5N1 Pandemic Flu Vaccines
GlaxoSmithKline Initiates Human Trial Program With Two H5N1 Pandemic Flu Vaccines
HSMN NewsFeed - 13 Mar 2006
AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases
AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases
HSMN NewsFeed - 25 Jan 2006
Generex Biotechnology Announces Interim Results of Clinical Breast Cancer Trials
Generex Biotechnology Announces Interim Results of Clinical Breast Cancer Trials
HSMN NewsFeed - 23 Jan 2006
Generex Biotechnology Announces FDA Pre-IND Meeting Scheduled for the Avian Flu Vaccine
Generex Biotechnology Announces FDA Pre-IND Meeting Scheduled for the Avian Flu Vaccine
Additional items found! 7

Members Archive contains
7 additional stories matching:
H5N1
(Password required)
H5N1
(Password required)